Cancer statistics, 2018
Top Cited Papers
- 4 January 2018
- journal article
- research article
- Published by Wiley in CA: A Cancer Journal for Clinicians
- Vol. 68 (1), 7-30
- https://doi.org/10.3322/caac.21442
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2014, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2015, were collected by the National Center for Health Statistics. In 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the United States. Over the past decade of data, the cancer incidence rate (2005‐2014) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2006‐2015) declined by about 1.5% annually in both men and women. The combined cancer death rate dropped continuously from 1991 to 2015 by a total of 26%, translating to approximately 2,378,600 fewer cancer deaths than would have been expected if death rates had remained at their peak. Of the 10 leading causes of death, only cancer declined from 2014 to 2015. In 2015, the cancer death rate was 14% higher in non‐Hispanic blacks (NHBs) than non‐Hispanic whites (NHWs) overall (death rate ratio [DRR], 1.14; 95% confidence interval [95% CI], 1.13‐1.15), but the racial disparity was much larger for individuals aged <65 years (DRR, 1.31; 95% CI, 1.29‐1.32) compared with those aged ≥65 years (DRR, 1.07; 95% CI, 1.06‐1.09) and varied substantially by state. For example, the cancer death rate was lower in NHBs than NHWs in Massachusetts for all ages and in New York for individuals aged ≥65 years, whereas for those aged <65 years, it was 3 times higher in NHBs in the District of Columbia (DRR, 2.89; 95% CI, 2.16‐3.91) and about 50% higher in Wisconsin (DRR, 1.78; 95% CI, 1.56‐2.02), Kansas (DRR, 1.51; 95% CI, 1.25‐1.81), Louisiana (DRR, 1.49; 95% CI, 1.38‐1.60), Illinois (DRR, 1.48; 95% CI, 1.39‐1.57), and California (DRR, 1.45; 95% CI, 1.38‐1.54). Larger racial inequalities in young and middle‐aged adults probably partly reflect less access to high‐quality health care. CA Cancer J Clin 2018;68:7‐30 . © 2018 American Cancer Society .Keywords
This publication has 55 references indexed in Scilit:
- Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2013
- Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992–2008Cancer Epidemiology, Biomarkers & Prevention, 2012
- Predicting US‐ and state‐level cancer counts for the current calendar yearCancer, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningThe New England Journal of Medicine, 2011
- Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future ratesCancer, 2009
- Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco ControlJNCI Journal of the National Cancer Institute, 2008
- The Reversal of Fortunes: Trends in County Mortality and Cross-County Mortality Disparities in the United StatesPLoS Medicine, 2008
- Quantifying the role of PSA screening in the US prostate cancer mortality declineCancer Causes & Control, 2007
- Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992–2001Cancer, 2006
- Long-term trends in cancer mortality in the United States, 1930-1998Cancer, 2003